[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606032":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":24,"centralContacts":29,"locations":35,"responsibleParty":54,"collaborators":24,"id":57,"slug":24,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":24,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":24,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":24,"overallStatus":37,"whyStopped":24,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"TFP group","EXPERIMENTAL","Patients will receive spinal anesthesia (using 2.5 mL of hyperbaric bupivacaine 0.5%) with bilateral transversalis fascia plane (TFP) block (using 20 mL of bupivacaine 0.25%) at the end of surgery.",[13],"Other: Transversalis fascia plane block",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group","ACTIVE_COMPARATOR","Patients will receive spinal anesthesia (using 2.5 mL of hyperbaric bupivacaine 0.5%) + (5 µg intrathecal dexmedetomidine diluted in 0.5ml saline) with a sham block at the end of surgery.",[19],"Drug: Intrathecal dexmedetomidine",[21,25],{"type":6,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"Transversalis fascia plane block",[9],null,{"type":26,"name":27,"description":17,"armGroupLabels":28,"otherNames":24},"DRUG","Intrathecal dexmedetomidine",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":24,"email":34},"Mohammed S ElSharkawy, MD","CONTACT","00201148207870","mselsharkawy@med.tanta.edu.eg",[36],{"facility":5,"status":37,"city":38,"state":39,"zip":40,"country":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Tanta","El-Gharbia","31527","Egypt",{"type":43,"coordinates":44},"Point",[45,46],31.00192,30.78847,{"lat":46,"lon":45},[49,51],{"name":50,"role":32,"phone":33,"phoneExt":24,"email":34},"Mohammed S Elsharkawy, MD",{"name":52,"role":53,"phone":24,"phoneExt":24,"email":24},"Saad A Moharam, MD","PRINCIPAL_INVESTIGATOR",{"type":53,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"Mohammed Said ElSharkawy","Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.","100606032",false,"NCT07170267","Transversalis Fascia Plane Block Versus Intrathecal Dexmedetomidine in Patients Undergoing Cesarean Section","Analgesic Efficacy of Transversalis Fascia Plane Block Versus Intrathecal Dexmedetomidine in Patients Undergoing Cesarean Section: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Age from 18 to 40 years.\n* American Society of Anesthesiology (ASA) physical status II.\n* Women undergoing cesarean section under spinal anesthesia.\n\nExclusion Criteria:\n\n* Contraindication to spinal anesthesia.\n* Women with body mass index \\>40 kg\u002Fm2.\n* Pregnancy-induced hypertension\n* Local infection at the site of injection.\n* Known cardiovascular disease\n* Coagulation abnormality.\n* History of chronic pain.\n* Abuse of drugs or alcohol.\n* History of allergies to any study medications.\n* Seizure disorders.\n* Any pregnancy complications requiring conversion to general anesthesia.","FEMALE","18 Years","40 Years",{"count":67,"type":68},50,"ESTIMATED","INTERVENTIONAL",[71],"NA","This study aims to compare the analgesic efficacy of the transversalis fascia plane (TFP) block and intrathecal dexmedetomidine in patients undergoing cesarean section (CS).",[74,75,76],"Transversalis Fascia Plane Block","Intrathecal Dexmedetomidine","Cesarean Section","2025-09-13",{"date":79,"type":80},"2025-09-16","ACTUAL",{"date":77,"type":80},{"date":83,"type":68},"2026-03-01",{"name":5,"class":6},1]